Zydus Lifesciences Limited (NSEI:ZYDUSLIFE) is looking for acquisitions. Zydus Lifesciences will continue to pursue strategic acquisitions, particularly in specialty and rare disease segments, company officials said over an earnings call. Sharvil Patel, managing director, Zydus Lifesciences, said, "We are confident our pipeline will drive overall growth visibility while future growth engines begin to deliver." "Our near-term priorities are clear: maintain consistent quality standards, integrate our recent acquisitions, and capture synergies swiftly." "Our strong balance sheet ensures we have the flexibility to invest and strengthen our businesses further".